Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging
Andrea Rodríguez-Agustín, Víctor Casanova, Judith Grau-Expósito, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 917-917
Open Access | Times Cited: 10

Showing 10 citing articles:

Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning
Paulina Glajzner, Agnieszka Bernat, Magdalena Jasińska-Stroschein
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Tyrosine kinase inhibitors modulate the expression of peroxiredoxins 1 and 2 in chronic myeloid leukemia cells
Hiroshi Kazama, Yan-Hua Wang, Junji Tanaka
Leukemia Research Reports (2025), pp. 100508-100508
Open Access
Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors
Julia Krushkal, Yingdong Zhao, Kyle Roney, et al.
Epigenetics (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Targeting the tumor microenvironment for treating double-refractory chronic lymphocytic leukemia
Richard Lewis, Alexander F. vom Stein, Michael Hallek
Blood (2024) Vol. 144, Iss. 6, pp. 601-614
Open Access | Times Cited: 3
Microvascular rarefaction caused by the NOTCH signaling pathway is a key cause of TKI-apatinib-induced hypertension and cardiac damage
Wenjuan Wang, Guodong Li, Jie Ma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Rejuvenation Strategy for Inducing and Enhancing Autoimmune Response to Eliminate Senescent Cells
Xingyue Wang, Chengyu Zhang, Jiahong Su, et al.
Aging and Disease (2024)
Open Access | Times Cited: 1
Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19
Sara Rodríguez-Mora, Magdalena Corona, Miriam Solera Sainero, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5066-5066
Open Access | Times Cited: 3
Multi-factor optimization and interaction analysis for enhanced nanobubble formulation and performance of Dasatinib
Kishore Kumar Boddu, Kumar Shiva Gubbiyappa
Journal of Drug Delivery Science and Technology (2024) Vol. 101, pp. 106112-106112
Closed Access
Sustained antiviral response against in vitro HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinib
Mario Manzanares, Fernando Ramos-Martín, Sara Rodríguez-Mora, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
A multiparametric screen uncovers FDA-approved small molecules that potentiate the nuclear mechano-dysfunctions in ATR-defective cells
Maria Rosaria, Giulia Bastianello, Divya Purushothaman, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Page 1

Scroll to top